ADTH Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of AdTheorent Holding Company, Inc. Is Fair to Shareholders
NEW YORK–(BUSINESS WIRE)–Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of AdTheorent Holding Company, Inc. (NASDAQ:... Read more.
Bayer Appoints Sue Ann Pentecost as Vice President, Head of U.S. Pharmaceutical Communications
WHIPPANY, N.J.–(BUSINESS WIRE)–Bayer today announced Sue Ann Pentecost as the new Vice President, Head of Pharmaceuticals Communications in the United... Read more.
HKW Strengthens Investment Team Across Core Competencies with Two New Partners
New Hires Support HKW’s Plan to Focus Investments in Business Services, Manufacturing and Other Sectors INDIANAPOLIS & NEW YORK–(BUSINESS... Read more.
Sam’s Club Business Membership Guide (2024) Published by Better Business Advice
NEW YORK–(BUSINESS WIRE)–Better Business Advice, a leading authority in business insights and resources, has released an in-depth article delving into... Read more.
Earnix Appoints Craig Campestre as Chief Revenue Officer to Drive Strategic Growth
BOSTON–(BUSINESS WIRE)–Earnix, the leading global provider of AI-based SaaS solutions for financial services, today announced the appointment of Craig... Read more.
SafeSport Implementing Improvements to Increase Efficiency and Information Sharing
Eight-month review, stakeholder engagement results in significant process changes DENVER–(BUSINESS WIRE)–The U.S. Center for SafeSport (the Center) today... Read more.
Pembina Pipeline Corporation Announces Closing of Acquisition of Enbridge’s Interest in Alliance/Aux Sable and Raises 2024 Guidance
CALGARY, Alberta–(BUSINESS WIRE)–Pembina Pipeline Corporation (“Pembina” or the “Company”) (TSX: PPL; NYSE: PBA) is pleased to... Read more.
Clinical Collaboration Agreement between Teva and Launch Therapeutics to Accelerate Development of Dual-Action Asthma Rescue Inhaler (ICS-SABA/TEV-’248) Respiratory Program; Teva and Abingworth Enter Strategic Development Funding Agreement
Collaboration combines Teva’s expertise in respiratory technology development and Launch Therapeutics’ innovative late-stage drug development model... Read more.
Incyte and CMS Announce Collaboration and License Agreement for Povorcitinib, an Oral JAK1 Inhibitor, in Mainland China, Hong Kong, Macau, Taiwan and Southeast Asia
Povorcitinib, a selective oral JAK1 inhibitor discovered by Incyte, is an investigational medicine being evaluated for the treatment of non-segmental vitiligo, hidradenitis... Read more.
Amprius Sets April 2024 Events Schedule
FREMONT, Calif.–(BUSINESS WIRE)–Amprius Technologies, Inc. (“Amprius” or the “Company”) (NYSE: AMPX), a leader in next-generation... Read more.